Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
enzalutamide (xtandi) (2 trials)
fulvestrant (faslodex) (1 trial)
nuv-422 (3 trials)
nuv-868 (1 trial)
olaparib (lynparza) (1 trial)
Glioma (Phase 2)
Trials (4 total)
Trial APIs (5 total)